Companies / BOC Sciences / Pertuzumab
BOC Sciences

Pertuzumab | BOC Sciences

Pertuzumab is a humanized IgG1 monoclonal antibody and a HER2 dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
  • See More